AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04908553 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Remimazolam Tosilate for Injection 0.15mg/kg
Description: Remimazolam Tosilate for Injection 0.15mg/kg at induction
Study NCT04908553 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Remimazolam Tosilate for Injection 0.2mg/kg
Description: Remimazolam Tosilate for Injection 0.2mg/kg at induction
Study NCT06267664 — intervention group
Intervention type: DRUG
Intervention: Patients with migraine treated with triptans, Lasmiditan or Gepants
Description: Patients will complete the study information in their smartphones, tablets or computers, using a QR code or a link that will redirect hem to the study questionnaires. RedCap will be used in the study.
Study NCT04699461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Loncastuximab Tesirine
Description: IV infusion
Study NCT04699461 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Idelalisib
Description: Oral tablet
Study NCT05261009 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peri-capsular Nerve Group (PENG)
Description: PENG block for postoperative pain management
Study NCT05261009 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar Plexus Block (LPB)
Description: LPB for postoperative pain management
Study NCT05476029 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood samples and alveolar lavage fluid were collected
Description: Blood samples and alveolar lavage fluid were collected for exosome sorting and identification, differential miRNAs, and analysis of serum oxidation and inflammatory indicators.
Study NCT05928494 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scenario-based high-fidelity simulation method
Description: Postpartum care applications were carried out with the high-reality Gaumard Scientific brand, product code: S550.100 Noella simulator in the simulation laboratory of the midwifery department to the students in the intervention group.
Study NCT06130462 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Aluminum
Description: Different concentrations of aluminium added to the blood test in vitro
Study NCT06130462 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Tetanus toxoid
Description: Used as control substance
Study NCT05713435 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intravaginal laser
Description: application of intravaginal laser
Study NCT05713435 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: intravaginal laser
Description: application of intravaginal laser
Study NCT04739579 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: C-Reactive Protein
Description: C-Reactive Protein trend in post-operative course
Study NCT04841772 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Recover Vegan Protein Supplement
Description: Post exercise protein supplement (26g pea protein)
Study NCT04841772 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Post exercise placebo supplement (32g maltodextrin)
Study NCT05818215 — intervention group
Intervention type: OTHER
Intervention: NO intervention
Description: NO intervention
Study NCT04335227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structured yoga therapy program
Description: Structured yoga therapy prepared according to traditional yoga scriptures of Patanjali yoga sutras will be administered to 32 females with PCOS. The structured yoga therapy which includes, Surya Namaskara (Sun Salutation) and asanas performed in four positions, standing, sitting, supine and prone for total duration of 60 minutes. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian
Study NCT04335227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program
Description: Thirty two females with PCOS in aerobic exercise (AE) group will be subjected to aerobic training of moderate intensity for 30-60 minutes six days per week for 12 weeks, in the light of guidelines framed by American College of Sports Medicine (ACSM). Aerobic exercise volume for each female recruited will be set at greater than 500 and up to 1000 MET-min/week, which will be approximately equal to 1000 kcal/week. They will be made sure that they exercise for minimum duration of 150 min/week and thereby covering 5400 to 7900 steps/day in pedometer readings. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian
Study NCT04335227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined yoga and aerobic training program
Description: Thirty two females with PCOS in combined yoga therapy and aerobic exercise (cYTAE) group will be subjected to three days of structured yoga therapy and three days of aerobic training of vigorous intensity. In addition to this, they will be asked to undergo nutritional management uniquely prepared by dietitian
Study NCT04335227 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional management
Description: Thirty two females with PCOS will be asked to undergo only nutritional management uniquely prepared by dietitian
Study NCT05619939 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein isolate
Description: The indicated protein isolates will be given to subjects as their major protein source
Study NCT05560412 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Zein nanocapsules
Description: 1 g of Zein nanoencapsulated daily
Study NCT05560412 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: 1 g of Zein non-encapsulated daily
Study NCT06337708 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smart Walk
Description: Smart Walk is a culturally tailored, Social Cognitive Theory-based multi-component smartphone delivered physical activity (PA) promotion intervention that delivered through the Smart Walk application, virtual physical activity coaching, and text messages. The Smart Walk smartphone application includes four key features: 1) personal profile pages, 2) culturally relevant multi-media physical activity promotion modules, 3) discussion boards, and 4) physical activity self-monitoring/tracking feature that integrates with Fitbit activity monitors for participants to track their daily, weekly, and monthly activity. Virtual physical activity coaches will actively engage and facilitate group-based dialogue among participants on the app discussion boards and provide individualized, one-on-one PA coaching via telephone or commercially available app-based video teleconferencing software (i.e., FaceTime, Zoom, Google hangouts).
Study NCT06337708 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Fitbit
Description: This intervention group will receive a Fitbit activity monitor and be encouraged to use the commercially available device to increase physical activity.
Study NCT03959982 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HHHFA Device
Description: Participants will be instructed to use the HHHFA for at least 4 hours during their sleep but will be allowed to use it as long as they want during sleep.
Study NCT03959982 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Spirometry
Description: Pre and post spirometry using albuterol.
Study NCT03959982 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Spirometry
Description: Pre and post spirometry using albuterol.
Study NCT03959982 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 6-minute walk
Description: 6-minute walk
Study NCT03959982 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 6-minute walk
Description: 6-minute walk
Study NCT03959982 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: CT scan
Description: CT scan
Study NCT03959982 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CT scan
Description: CT scan
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical Research Council dyspnea scale (MRC)
Description: MRC questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Research Council dyspnea scale (MRC)
Description: MRC questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: St. George's Respiratory Questionnaire (SGRQ)
Description: SGRQ questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: St. George's Respiratory Questionnaire (SGRQ)
Description: SGRQ questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: COPD Assessment Test (CAT)
Description: CAT questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COPD Assessment Test (CAT)
Description: CAT questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pittsburgh Sleep Quality Index (PSQI)
Description: PSQI questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI)
Description: PSQI questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CASA-Q
Description: CASA-Q questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CASA-Q
Description: CASA-Q questionnaire
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spirehealth Tag Device
Description: Subjects will wear the Spirehealth Tag Device to measure heart rate, respiratory rate, sleep time, physical activity (movement), and calories burned with activity.
Study NCT03959982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spirehealth Tag Device
Description: Subjects will wear the Spirehealth Tag Device to measure heart rate, respiratory rate, sleep time, physical activity (movement), and calories burned with activity.
Study NCT06246812 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Deans' Fit Family Challenge
Description: An annual 8-week physical activity and weight loss competition between VCOM-Auburn, AU College of Nursing, and AU Harrison School of Pharmacy
Study NCT06246812 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text message
Description: Three text messages per week to promote and motive physical activity
Study NCT05553392 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: StrataXRT
Description: StrataXRT is a full contact flexible wound dressing for the prevention and treatment of radiation dermatitis. StrataXRT is a semi-occlusive, self-drying and transparent gel.~When used as directed StrataXRT dries to form a protective layer that is gas permeable and waterproof which hydrates and protects compromised skin areas and superficial wounds from chemical and microbial invasion. StrataXRT may be directly applied to radiation dermatitis, compromised skin surfaces, superficial wounds and first and second degree burns.
Study NCT05553392 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aquaphor
Description: Aquaphor is a brand of over-the-counter (OTC) skin care ointments manufactured by Beiersdorf Inc.~Aquaphor contains 41 percent petrolatum (or petroleum jelly), the active ingredient, temporarily protects minor cuts, scrapes, and burns; protects and helps relieve chapped or cracked skin and lips; helps protect from the drying effects of wind and cold weather.
Study NCT04865354 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Verofilcon A contact lenses
Description: Spherical soft contact lenses for daily disposable wear
Study NCT04865354 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Somofilcon A contact lenses
Description: Spherical soft contact lenses for daily disposable wear
Study NCT05126147 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Compare the effects of hydroxychloroquine 200mg twice daily for 6 months with those without treatment.
Study NCT04922203 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: in Situ Simulation
Description: 2 sessions of in situ simulation with 4 crisis scenarios and debriefing focused on non technical skills
Study NCT04882579 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Point-of-care-ultrasound examination
Description: The intervention consists of three ultrasound modalities:~1. Cardiac ultrasound assessing signs of right ventricular strain or other obvious pathology.~2. Deep venous ultrasound assessing presence of a deep venous thrombus~3. Lung ultrasound assessing presence of pulmonary infarctions, pleural effusion, pneumothorax or interstitial syndrome.
Study NCT05750927 — intervention group
Intervention type: PROCEDURE
Intervention: Transcatheter aortic valve intervention (TAVI) and percutaneous coronary intervention (PCI)
Description: TAVI and PCI to be administered as per physician's indication and choice, in one or more stages
Study NCT05071183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPX-0005
Description: Oral TPX-0005 capsules
Study NCT04524195 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [18F]F-AraG Injection
Description: Single dose of 5 mCi+/- \[18F\]F-AraG IV injection followed by the PET/CT scan. A baseline \[18F\]F-AraG PET/CT will be performed at about 0-7 days before patient receives the first dose of PD-1/PD-L1 immunotherapy. A second \[18F\]F-AraG PET-CT will be performed at less than 14 days after the first dose of PD-1/PD-L1 immunotherapy is administered and before the second dose of PD-1/PD-L1 immunotherapy is given.
Study NCT05071183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Oral trametinib tablets
Study NCT04307446 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality
Description: Immersive Virtual Reality
Study NCT06400433 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided median nerve hydrodissection
Description: Injected wrist will be supinated and slightly dorsiflexed. The transducer of the ultrasound will be placed transversely at the proximal carpal inlet. After sterile preparation, a 22 gauge needle will be inserted using the short-axis technique, in-plane ulnar approach. During hydrodissection, separation of either between the median nerve and flexor retinaculum or between the median nerve and the underlying flexor tendons will be visually confirmed.
Study NCT04881357 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: test mouth rinse (Lacer Oros Acción Integral - new formula, Barcelona, Spain).
Description: The experimental group will use three times daily a provided manual toothbrush with a sodium fluoride dentifrice, followed by the use of the test mouth rinse (Lacer Oros Acción Integral - new formula, Barcelona, Spain).
Study NCT04881357 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control group
Description: The control group will use three times daily a provided manual toothbrush with a sodium fluoride dentifrice, followed by the use of the control mouth rinse (Lacer Oros Acción Integral - new formula, without active ingredients, Barcelona, Spain).
Study NCT06042582 — intervention group
Intervention type: PROCEDURE
Intervention: Additional biopsies collection
Description: We will recruit only subjects (UC, CD and NO-UC/CD) scheduled for the endoscopy and biopsies-collection according to the usual clinical practice. During the endoscopy we will collect 6 additional biopsies.
Study NCT06209229 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sodium nucleinate
Description: * Calcitriol- 5000 units in the morning before meals every other day 21 days and the next 3 weeks after the end of therapy.~* Magnesium (in the form of lactate dihydrate) 470 mg + pyridoxine (in the form of hydrochloride) 5 mg - take orally 3 tablets per meter square of body surface area, in the evening 2 hours before bedtime, 21 days and the next 3 weeks after the end of therapy.~* Quercetin from onion juice - take orally 1000 mg in the morning before meals, 21 days, as well as the next 3 weeks after the end of therapy.~* sodium oligodinucleatide orally at the rate of 2 tablets under the tongue per meter square of body surface, in the morning 15 minutes before meals every other day, a total of 5 times (1, 3, 5, 7 , 9 day from the beginning of therapy), then after 21 days to repeat the course for 3 months.~* Spray natirium nucleonate 4 doses in the morning on the hyoid, suck, do not swallow for 3-5 minutes, once every 4 days for 21 days.
Study NCT06583434 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: core-lower extremity Pilates Training Group
Description: Participants in this group will engage in a stabilization-based Pilates exercise program focusing on core and lower extremity stabilization. The program consists of twice-weekly sessions, each lasting 50 minutes, over a period of 8 weeks. The primary goal of the intervention is to improve gait patterns and balance in women with flexible pes planus
Study NCT05142423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK109+AK104
Description: It includes dose escalation and dose expansion stage. 6-12 patients will be enrolled in dose escalation stage for safety and efficacy. Then select specific dose of AK104 and AK109. Expand for the further safety and efficacy study.
Study NCT05875233 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Elix Daily Harmony
Description: Elix Daily Harmony is a clinical-strength, organic blend of hormone-balancing Traditional Chinese Medicine (TCM) herbs and adaptogens. Contains Angelica Sinensis, licorice, ginger, Bupleurum, Cyperus Rotundus, White Peony, Mint, Poria, Atractylodes, White Ginseng, Reishi, Rehmannia Root, and Astragalus.~Participants should add 3 droppers full (half a teaspoon or 2.5 ml) of Elix Daily Harmony to their tea or other warm or room temperature beverage each morning, 1-2 hours after their first meal. The product should not be taken with iced drinks or with food.
Study NCT05875233 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Elix Cycle Balance
Description: A tailored blend of medicinal herbs to holistically support menstrual symptoms by treating underlying imbalances. Participants should take 3 droppers full (half a teaspoon or 2.5 ml) of Elix Cycle Balance daily before bed with tea or other warm or room temperature beverage. The product should not be taken with iced drinks or with food.
Study NCT06583434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Training Group
Description: Participants in this group will not receive any specific intervention during the study period. They will continue their usual activities without any additional exercises provided by the study.
Study NCT06106763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala coloring
Description: Mandala coloring page
Study NCT05899972 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo technique
Description: With the volunteer in a supine position, the researcher placed the palms of their hands on the patient's shoulders. The contact is made with the hands on the shoulder blades of the volunteer for 6 minutes.
Study NCT05899972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suboccipital inhibition technique
Description: With the volunteer in a supine position, the investigator is sitting position at the patient's bedside. The investigator starts by placing both hands under the patient's head in the occipital region. After palpating the suboccipital muscles, the investigator uses the second, third and fourth fingers of both hands flexed against the muscle belly and remains in this position.
Study NCT05899972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Frontal lift technique
Description: With the volunteer in a supine position, the investigator is sitting position at the patient's bedside. The investigator positions the tips of both index fingers on either side of the metopic suture while the third finger remains resting on the frontal bone so that the tips of the fourth fingers contact the zygomatic processes bilaterally. A slight pressure is applied with the index fingers and an anterior pressure is performed.
Study NCT05899972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Parietal lift technique
Description: With the volunteer in a supine position, the investigator is sitting position at the patient's bedside. The investigator places the palms on the lateral edges of the parietal bones and the thumbs crossed at the sagittal suture. First, a medial pressure is administered with the second, third and fourth fingers and then a cephalic traction is performed.
Study NCT05899972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IV ventricle technique
Description: With the volunteer in a supine position, the investigator is sitting position at the patient's bedside. The investigator positions his hands in a shell and thumbs together at the level of the spinous apophyses of the patient's second or third cervical vertebra.
Study NCT06507800 — intervention group
Intervention type: OTHER
Intervention: Observational cohort
Description: Cancer incidence after AHSCT for an autoimmune indication.
Study NCT06256419 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist
Description: Eligible patients with T2DM were required to have received GLP-1RA as monotherapy or in combination with other antidiabetic agents. GLP-1 RA was injected subcutaneously at standard dose and frequency for consecutive 6 months in patients with T2DM.